Tapewire

NYSE · USD

PRKS

United Parks & Resorts Inc.

Export transactions ↓
Tapewire entity
4601
SEC CIK
0001564902
Parsed reports
923

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 13, 2023 Filed Jun 14, 2023 20:00 UTC GrantCommon Stock 2,951 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-036999 · doc4.xml · nonDerivative · entry 1

Schaefer Kimberly · CIK 0001335887 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,910

F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan and vests 100% on the day before the 2024 Annual Stockholder's Meeting of the Issuer.

Read SEC document
June 13, 2023 Filed Jun 14, 2023 20:00 UTC GrantCommon Stock 2,951 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-036995 · doc4.xml · nonDerivative · entry 1

Hartnett Timothy · CIK 0001833849 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,895

F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan and vests 100% on the day before the 2024 Annual Stockholder's Meeting of the Issuer.

Read SEC document
June 13, 2023 Filed Jun 14, 2023 20:00 UTC GrantCommon Stock 2,951 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-036998 · doc4.xml · nonDerivative · entry 1

Narang Neha Jogani · CIK 0001789425 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,571

F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan and vests 100% on the day before the 2024 Annual Stockholder's Meeting of the Issuer.

Read SEC document
June 13, 2023 Filed Jun 14, 2023 20:00 UTC GrantCommon Stock 2,951 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-036997 · doc4.xml · nonDerivative · entry 1

Maruyama Yoshikazu · CIK 0001710109 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,022

F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan and vests 100% on the day before the 2024 Annual Stockholder's Meeting of the Issuer.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 21:07 UTC GrantCommon Stock, par value $0.01 2,951 $0.00 $0.00
Disclosure

SEC source: 0000921895-23-001508 · form411269002cha_06152023.xml · nonDerivative · entry 1

CHAMBERS JAMES P. · CIK 0001778860 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,302

F1 · shares: Represents deferred stock units granted pursuant to the Issuer's 2017 Omnibus Incentive Plan, which vest 100% on the day before the 2024 Annual Stockholder's Meeting of the Issuer. The shares subject to these units will be issued to Mr. Chambers three months after his "separation from service" as a director pursuant to the terms of the award agreement.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 21:11 UTC
HEP FUND LP10% owner
HM FUND LP10% owner
HE GP LLC10% owner
HM GP LLC10% owner
GrantCommon Stock 2,951 $0.00 $0.00
Disclosure

SEC source: 0000921895-23-001510 · form411269002b_06152023.xml · nonDerivative · entry 1

Hill Path Capital Partners Co-Investment S LP · CIK 0001710571 · 10% owner

Hill Path Capital Partners S GP LLC · CIK 0001711306 · 10% owner

Hill Path Holdings LLC · CIK 0001676388 · 10% owner

HEP FUND LP · CIK 0001778825 · 10% owner

HM FUND LP · CIK 0001778807 · 10% owner

HE GP LLC · CIK 0001778844 · 10% owner

HM GP LLC · CIK 0001778909 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Scott Ross

Disclosed balance after: 64,610

F1 · security: This Form 4 is filed jointly by Hill Path Capital Partners LP ("Hill Path Capital"), Hill Path Co-Investment Partners LP ("Hill Path Co-Investment"), Hill Path Capital Partners-H LP ("Hill Path H"), Hill Path Capital Partners Co-Investment E LP ("Hill Path E"), Hill Path Capital Partners Co-Investment E2 LP ("Hill Path E2"), Hill Path Capital Partners Co-Investment S LP ("Hill Path S"), HEP Fund LP ("HEP Fund"), HM Fund LP ("HM Fund"), Hill Path Capital Partners GP LLC ("Hill Path GP"), Hill Path Capital Partners E GP LLC ("Hill Path E GP"), Hill Path Capital Partners S GP LLC ("Hill Path S GP"), HE GP LLC ("HE GP"), HM GP LLC ("HM GP"), Hill Path Investment Holdings LLC ("Hill Path Investment Holdings"), Hill Path Capital LP ("Hill Path"), Hill Path Holdings LLC ("Hill Path Holdings") and Scott Ross ("Mr. Ross," and collectively with the aforementioned entities, the "Reporting Persons").

F2 · security: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the second of two identical reports relating to the same transactions being filed with the Securities and Exchange Commission. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group along with HAT Fund LP and HAT Fund II LP, which do not beneficially own any shares of Common Stock, that collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Mr. Ross is also a director of the Issuer. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan and vests 100% on the day before the 2024 Annual Stockholder's Meeting of the Issuer.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 21:09 UTC
ROSS SCOTT IDirector · 10% owner
GrantCommon Stock 2,951 $0.00 $0.00
Disclosure

SEC source: 0000921895-23-001509 · form411269002a_06152023.xml · nonDerivative · entry 1

Hill Path Capital Partners LP · CIK 0001661914 · 10% owner

Hill Path Capital Partners-H LP · CIK 0001661915 · 10% owner

Hill Path Capital Co-Investment Partners LP · CIK 0001661913 · 10% owner

Hill Path Capital Partners Co-Investment E LP · CIK 0001705700 · 10% owner

Hill Path Capital Partners Co-Investment E2 LP · CIK 0001705698 · 10% owner

Hill Path Capital Partners GP LLC · CIK 0001676386 · 10% owner

Hill Path Capital Partners E GP LLC · CIK 0001705699 · 10% owner

Hill Path Investment Holdings LLC · CIK 0001676389 · 10% owner

Hill Path Capital LP · CIK 0001676292 · 10% owner

ROSS SCOTT I · CIK 0001549220 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Scott Ross

Disclosed balance after: 64,610

F1 · security: This Form 4 is filed jointly by Hill Path Capital Partners LP ("Hill Path Capital"), Hill Path Co-Investment Partners LP ("Hill Path Co-Investment"), Hill Path Capital Partners-H LP ("Hill Path H"), Hill Path Capital Partners Co-Investment E LP ("Hill Path E"), Hill Path Capital Partners Co-Investment E2 LP ("Hill Path E2"), Hill Path Capital Partners Co-Investment S LP ("Hill Path S"), HEP Fund LP ("HEP Fund"), HM Fund LP ("HM Fund"), Hill Path Capital Partners GP LLC ("Hill Path GP"), Hill Path Capital Partners E GP LLC ("Hill Path E GP"), Hill Path Capital Partners S GP LLC ("Hill Path S GP"), HE GP LLC ("HE GP"), HM GP LLC ("HM GP"), Hill Path Investment Holdings LLC ("Hill Path Investment Holdings"), Hill Path Capital LP ("Hill Path"), Hill Path Holdings LLC ("Hill Path Holdings") and Scott Ross ("Mr. Ross," and collectively with the aforementioned entities, the "Reporting Persons").

F2 · security: To enable the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions being filed with the Securities and Exchange Commission. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group along with HAT Fund LP and HAT Fund II LP, which do not beneficially own any shares of Common Stock, that collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Mr. Ross is also a director of the Issuer. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan and vests 100% on the day before the 2024 Annual Stockholder's Meeting of the Issuer.

Read SEC document
May 18, 2023 Filed May 18, 2023 20:00 UTC
Swanson MarcChief Executive Officer
SaleCommon Stock 4,000 $55.81 $223,240.00
Disclosure

SEC source: 0001209191-23-030578 · doc4.xml · nonDerivative · entry 1

Swanson Marc · CIK 0001570328 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,537

F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 11, 2022.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionEmployee Stock option (right to buy) · Derivative 2,756 $0.00 Strike: $27.21 $0.00
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · derivative · entry 14

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,756 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option, representing a right to purchase a total of 2,756 shares, became exercisable in two equal annual installments beginning on February 28, 2021, which was the first anniversary of the date on which the option was granted.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionEmployee Stock option (right to buy) · Derivative 4,202 $0.00 Strike: $25.70 $0.00
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · derivative · entry 13

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,202 shares

Expires 2029-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option, representing a right to purchase a total of 4,202 shares, became exercisable in three equal annual installments beginning on March 14, 2020, which was the first anniversary of the date on which the option was granted.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionEmployee Stock option (right to buy) · Derivative 1,945 $0.00 Strike: $25.70 $0.00
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · derivative · entry 12

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,945 shares

Expires 2029-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option, representing a right to purchase a total of 1,945 shares, became exercisable in three equal annual installments beginning on March 14, 2020, which was the first anniversary of the date on which the option was granted.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionEmployee Stock option (right to buy) · Derivative 1,933 $0.00 Strike: $14.17 $0.00
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · derivative · entry 11

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,933 shares

Expires 2026-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option, representing a right to purchase a total of 1,933 shares, became exercisable in four equal annual installments beginning on July 1, 2017, which was the first anniversary of the date on which the option was granted.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionEmployee Stock option (right to buy) · Derivative 934 $0.00 Strike: $18.17 $0.00
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · derivative · entry 10

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 934 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option, representing a right to purchase a total of 934 shares, became exercisable in four equal annual installments beginning on March 1, 2017, which was the first anniversary of the date on which the option was granted.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionEmployee Stock option (right to buy) · Derivative 798 $0.00 Strike: $18.96 $0.00
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · derivative · entry 9

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 798 shares

Expires 2025-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, representing a right to purchase a total of 798 shares, became exercisable in four equal annual installments beginning on March 3, 2016, which was the first anniversary of the date on which the option was granted.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC SaleCommon Stock 12,568 $56.89 $714,993.52
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · nonDerivative · entry 7

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,709

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.59 to $57.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionCommon Stock 2,756 $27.21 $74,990.76
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · nonDerivative · entry 6

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,277

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionCommon Stock 4,202 $25.70 $107,991.40
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · nonDerivative · entry 5

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionCommon Stock 1,945 $25.70 $49,986.50
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · nonDerivative · entry 4

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,319

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionCommon Stock 1,933 $14.17 $27,390.61
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · nonDerivative · entry 3

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionCommon Stock 934 $18.17 $16,970.78
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · nonDerivative · entry 2

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,441

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC Exercise / conversionCommon Stock 798 $18.96 $15,130.08
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · nonDerivative · entry 1

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,507

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:00 UTC
Surrett ByronSee Remarks
SaleCommon Stock 144 $57.11 $8,223.84
Disclosure

SEC source: 0001209191-23-029401 · doc4.xml · nonDerivative · entry 2

Surrett Byron · CIK 0001961503 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,125

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC
Finazzo Christopher L.Chief Commercial Officer
GrantEmployee Stock option (right to buy) · Derivative 3,513 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029409 · doc4.xml · derivative · entry 1

Finazzo Christopher L. · CIK 0001801406 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,513

Underlying: Common Stock · 3,513 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC
Dold ChristopherChief Zoological Officer
GrantEmployee Stock option (right to buy) · Derivative 1,976 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029406 · doc4.xml · derivative · entry 1

Dold Christopher · CIK 0001671261 · Chief Zoological Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,976

Underlying: Common Stock · 1,976 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC
Adams Michelle FChief Transformation Officer
GrantEmployee Stock option (right to buy) · Derivative 3,513 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029407 · doc4.xml · derivative · entry 1

Adams Michelle F · CIK 0001934756 · Chief Transformation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,513

Underlying: Common Stock · 3,513 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC
Boyle ShekufehChief Accounting Officer
GrantEmployee Stock option (right to buy) · Derivative 966 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029405 · doc4.xml · derivative · entry 1

Boyle Shekufeh · CIK 0001964228 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 966

Underlying: Common Stock · 966 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC GrantEmployee Stock option (right to buy) · Derivative 1,647 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029410 · doc4.xml · derivative · entry 8

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,647

Underlying: Common Stock · 1,647 shares

Expires 2033-05-11

F2 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC
Surrett ByronSee Remarks
GrantEmployee Stock option (right to buy) · Derivative 1,647 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029401 · doc4.xml · derivative · entry 3

Surrett Byron · CIK 0001961503 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,647

Underlying: Common Stock · 1,647 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC
Surrett ByronSee Remarks
SaleCommon Stock 813 $57.29 $46,576.77
Disclosure

SEC source: 0001209191-23-029401 · doc4.xml · nonDerivative · entry 1

Surrett Byron · CIK 0001961503 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,269

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC GrantEmployee Stock option (right to buy) · Derivative 2,384 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029402 · doc4.xml · derivative · entry 1

Taylor George Anthony · CIK 0001570331 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,384

Underlying: Common Stock · 2,384 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC GrantEmployee Stock option (right to buy) · Derivative 1,877 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029404 · doc4.xml · derivative · entry 1

Forrester James W Jr · CIK 0001962573 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,877

Underlying: Common Stock · 1,877 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC
Hughes James ClarkChief Human Resources Officer
GrantEmployee Stock option (right to buy) · Derivative 1,098 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029408 · doc4.xml · derivative · entry 1

Hughes James Clark · CIK 0001943022 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,098

Underlying: Common Stock · 1,098 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:00 UTC
Swanson MarcChief Executive Officer
GrantEmployee Stock option (right to buy) · Derivative 7,905 $0.00 Strike: $56.92 $0.00
Disclosure

SEC source: 0001209191-23-029400 · doc4.xml · derivative · entry 1

Swanson Marc · CIK 0001570328 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,905

Underlying: Common Stock · 7,905 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The option becomes exercisable over three years, with one-third (1/3) becoming exercisable on each of the first three anniversaries of the date of grant.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:00 UTC
Dold ChristopherChief Zoological Officer
SaleCommon Stock 5,766 $60.46 $348,612.36
Disclosure

SEC source: 0001209191-23-028701 · doc4.xml · nonDerivative · entry 1

Dold Christopher · CIK 0001671261 · Chief Zoological Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,370

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $61.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:00 UTC
Swanson MarcChief Executive Officer
Tax withholdingCommon Stock 527 $58.98 $31,082.46
Disclosure

SEC source: 0001209191-23-028708 · doc4.xml · nonDerivative · entry 1

Swanson Marc · CIK 0001570328 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,537

F1 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock units.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:00 UTC Tax withholdingCommon Stock 47 $58.98 $2,772.06
Disclosure

SEC source: 0001209191-23-028706 · doc4.xml · nonDerivative · entry 2

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,709

F1 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock units.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:00 UTC
Surrett ByronSee Remarks
Tax withholdingCommon Stock 47 $58.98 $2,772.06
Disclosure

SEC source: 0001209191-23-028704 · doc4.xml · nonDerivative · entry 2

Surrett Byron · CIK 0001961503 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,082

F1 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock units.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:00 UTC Tax withholdingCommon Stock 187 $58.98 $11,029.26
Disclosure

SEC source: 0001209191-23-028702 · doc4.xml · nonDerivative · entry 1

Taylor George Anthony · CIK 0001570331 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,647

F1 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock units.

Read SEC document
May 09, 2023 Filed May 10, 2023 20:00 UTC
Dold ChristopherChief Zoological Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,216 $0.00 Strike: $25.70 $0.00
Disclosure

SEC source: 0001209191-23-028449 · doc4.xml · derivative · entry 5

Dold Christopher · CIK 0001671261 · Chief Zoological Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,432

Underlying: Common Stock · 1,216 shares

Expires 2029-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022.

F4 · derivative.exercise_date: The option, representing a right to purchase a total of 10,943 shares, became exercisable in three equal annual installments beginning on March 14, 2020, which was the first anniversary of the date on which the option was granted.

Read SEC document
May 09, 2023 Filed May 10, 2023 20:00 UTC
Dold ChristopherChief Zoological Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,225 $0.00 Strike: $27.21 $0.00
Disclosure

SEC source: 0001209191-23-028449 · doc4.xml · derivative · entry 4

Dold Christopher · CIK 0001671261 · Chief Zoological Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,450

Underlying: Common Stock · 1,225 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022.

F3 · derivative.exercise_date: The option, representing a right to purchase a total of 5,512 shares, became exercisable in three equal annual installments beginning on February 28, 2021, which was the first anniversary of the date on which the option was granted.

Read SEC document
May 09, 2023 Filed May 10, 2023 20:00 UTC
Dold ChristopherChief Zoological Officer
SaleCommon Stock 3,341 $60.00 $200,460.00
Disclosure

SEC source: 0001209191-23-028449 · doc4.xml · nonDerivative · entry 3

Dold Christopher · CIK 0001671261 · Chief Zoological Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,136

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 09, 2023 Filed May 10, 2023 20:00 UTC
Dold ChristopherChief Zoological Officer
Exercise / conversionCommon Stock 1,216 $25.70 $31,251.20
Disclosure

SEC source: 0001209191-23-028449 · doc4.xml · nonDerivative · entry 2

Dold Christopher · CIK 0001671261 · Chief Zoological Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,477

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022.

Read SEC document
May 09, 2023 Filed May 10, 2023 20:00 UTC
Dold ChristopherChief Zoological Officer
Exercise / conversionCommon Stock 1,225 $27.21 $33,332.25
Disclosure

SEC source: 0001209191-23-028449 · doc4.xml · nonDerivative · entry 1

Dold Christopher · CIK 0001671261 · Chief Zoological Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022.

Read SEC document
May 09, 2023 Filed May 11, 2023 20:00 UTC Tax withholdingCommon Stock 98 $59.66 $5,846.68
Disclosure

SEC source: 0001209191-23-028707 · doc4.xml · nonDerivative · entry 1

Forrester James W Jr · CIK 0001962573 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,585

F1 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock units.

Read SEC document
May 09, 2023 Filed May 11, 2023 20:00 UTC Tax withholdingCommon Stock 262 $59.66 $15,630.92
Disclosure

SEC source: 0001209191-23-028706 · doc4.xml · nonDerivative · entry 1

Miller Kyle Robert · CIK 0001961478 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,756

F1 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock units.

Read SEC document
May 09, 2023 Filed May 11, 2023 20:00 UTC
Surrett ByronSee Remarks
Tax withholdingCommon Stock 262 $59.66 $15,630.92
Disclosure

SEC source: 0001209191-23-028704 · doc4.xml · nonDerivative · entry 1

Surrett Byron · CIK 0001961503 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,129

F1 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock units.

Read SEC document
May 09, 2023 Filed May 11, 2023 20:00 UTC
Boyle ShekufehChief Accounting Officer
Tax withholdingCommon Stock 433 $59.66 $25,832.78
Disclosure

SEC source: 0001209191-23-028703 · doc4.xml · nonDerivative · entry 1

Boyle Shekufeh · CIK 0001964228 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

F1 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock units.

Read SEC document
March 31, 2023 Filed Apr 3, 2023 20:00 UTC GrantCommon Stock 571 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-022137 · doc4.xml · nonDerivative · entry 1

MOLONEY THOMAS E · CIK 0001109101 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,620

F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan.

Read SEC document
March 31, 2023 Filed Apr 3, 2023 20:00 UTC
Gray WilliamDirector
GrantCommon Stock 803 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-022127 · doc4.xml · nonDerivative · entry 1

Gray William · CIK 0001407133 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,484

F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan.

Read SEC document
March 31, 2023 Filed Apr 3, 2023 16:00 UTC GrantCommon Stock 613 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-022129 · doc4.xml · nonDerivative · entry 1

BENSION RONALD · CIK 0001242402 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,796

F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.